JP2015518837A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518837A5
JP2015518837A5 JP2015512890A JP2015512890A JP2015518837A5 JP 2015518837 A5 JP2015518837 A5 JP 2015518837A5 JP 2015512890 A JP2015512890 A JP 2015512890A JP 2015512890 A JP2015512890 A JP 2015512890A JP 2015518837 A5 JP2015518837 A5 JP 2015518837A5
Authority
JP
Japan
Prior art keywords
compound
salt
formula
process according
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518837A (ja
JP6214636B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/041624 external-priority patent/WO2013173736A1/en
Publication of JP2015518837A publication Critical patent/JP2015518837A/ja
Publication of JP2015518837A5 publication Critical patent/JP2015518837A5/ja
Application granted granted Critical
Publication of JP6214636B2 publication Critical patent/JP6214636B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512890A 2012-05-17 2013-05-17 ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス Active JP6214636B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648421P 2012-05-17 2012-05-17
US61/648,421 2012-05-17
US201361785281P 2013-03-14 2013-03-14
US61/785,281 2013-03-14
PCT/US2013/041624 WO2013173736A1 (en) 2012-05-17 2013-05-17 Process for making hydroxylated cyclopentylpyrimidine compounds

Publications (3)

Publication Number Publication Date
JP2015518837A JP2015518837A (ja) 2015-07-06
JP2015518837A5 true JP2015518837A5 (https=) 2016-07-07
JP6214636B2 JP6214636B2 (ja) 2017-10-18

Family

ID=48534507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512890A Active JP6214636B2 (ja) 2012-05-17 2013-05-17 ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス

Country Status (18)

Country Link
US (1) US9309204B2 (https=)
EP (1) EP2861583B1 (https=)
JP (1) JP6214636B2 (https=)
KR (1) KR20150020211A (https=)
CN (1) CN104487430B (https=)
AU (1) AU2013262568B2 (https=)
BR (1) BR112014028570A2 (https=)
CA (1) CA2873653A1 (https=)
DK (1) DK2861583T3 (https=)
ES (1) ES2588878T3 (https=)
IL (1) IL235714A0 (https=)
MA (1) MA37649B1 (https=)
MX (1) MX2014013865A (https=)
PL (1) PL2861583T3 (https=)
RU (1) RU2014151017A (https=)
SG (1) SG11201407613RA (https=)
SI (1) SI2861583T1 (https=)
WO (1) WO2013173736A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9416110B2 (en) 2012-05-17 2016-08-16 Array Biopharma Inc. Process for making hydroxylated cyclopentylpyrimidine compounds
HRP20180948T1 (hr) 2012-05-17 2018-08-10 Genentech, Inc. Postupak za proizvodnju aminokiselinskih spojeva
KR102678074B1 (ko) 2012-05-17 2024-06-26 제넨테크, 인크. 무정형 형태의 akt 저해성 피리미디닐 - 사이클로펜탄 화합물, 조성물 및 이들의 방법
EP2850200A1 (en) 2012-05-17 2015-03-25 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
SI3068770T1 (sl) 2013-11-15 2020-02-28 F. Hoffmann-La Roche Ag Postopki za pripravo pirimidinilciklopentanskih spojin
KR102284938B1 (ko) * 2013-11-27 2021-08-02 선샤인 레이크 파르마 컴퍼니 리미티드 다이하이드로피리미딘 유도체 및 이의 중간산물의 제조 방법
RU2732404C2 (ru) * 2014-09-26 2020-09-16 Ф. Хоффманн-Ля Рош Аг СПОСОБЫ ПОЛУЧЕНИЯ (ЦИКЛОПЕНТИЛ[d]ПИРИМИДИН-4-ИЛ)ПИПЕРАЗИНОВЫХ СОЕДИНЕНИЙ
CN115916758A (zh) 2020-06-16 2023-04-04 豪夫迈·罗氏有限公司 用于制备羟基化环戊基嘧啶化合物的方法
KR102689151B1 (ko) * 2021-09-06 2024-07-29 연세대학교 산학협력단 Akt 신호경로 억제제를 유효성분으로 포함하는 아토피피부염의 예방 또는 치료용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015684A1 (en) 1993-12-12 1995-06-15 Agrogene, Ltd. A novel method to protect plants from fungal infection
AU724216B2 (en) 1997-04-07 2000-09-14 Merck & Co., Inc. A method of treating cancer
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
AU3386600A (en) 1999-03-03 2000-09-21 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
DE60020560T2 (de) * 1999-06-03 2006-04-27 Teikoku Hormone Mfg. Co., Ltd. Substituierte pyrazol-derivate
AU7715300A (en) 1999-09-27 2001-04-30 Merck & Co., Inc. Method of preventing osteoporosis
CA2526506A1 (en) 2003-06-09 2004-12-16 Boehringer Ingelheim International Gmbh Inhibitors of papilloma virus
NZ590160A (en) 2003-11-21 2012-07-27 Array Biopharma Inc AKT protein kinase inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
UA95641C2 (xx) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
US8063050B2 (en) * 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
JP5157576B2 (ja) 2007-05-14 2013-03-06 住友化学株式会社 光学活性2−アルキル−1,1,3−トリアルコキシカルボニルプロパンの製造方法
CN101918373B (zh) 2007-07-05 2013-06-05 阵列生物制药公司 作为akt蛋白激酶抑制剂的嘧啶基环戊烷
US20100298289A1 (en) 2007-10-09 2010-11-25 Ucb Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
ES2422733T3 (es) 2008-01-09 2013-09-13 Array Biopharma Inc Pirimidilciclopentanos hidroxilados como inhibidores de proteínas cinasas AKT
AU2009303475B2 (en) * 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
US9278922B2 (en) 2009-04-15 2016-03-08 Abbvie Inc. Anti-viral compounds
EA020151B1 (ru) 2009-10-23 2014-09-30 Эли Лилли Энд Компани Ингибиторы akt и фармацевтические составы, их содержащие
US9050334B2 (en) 2010-07-16 2015-06-09 Innov88 Llc MIF inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
EP2850200A1 (en) 2012-05-17 2015-03-25 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
HRP20180948T1 (hr) 2012-05-17 2018-08-10 Genentech, Inc. Postupak za proizvodnju aminokiselinskih spojeva
US9416110B2 (en) 2012-05-17 2016-08-16 Array Biopharma Inc. Process for making hydroxylated cyclopentylpyrimidine compounds
US20140121193A1 (en) 2012-11-01 2014-05-01 Robert S. Katz Methods for treating fibromyalgia
CN105263910A (zh) 2013-02-18 2016-01-20 斯克利普斯研究所 具有治疗潜力的血管加压素受体调节剂
CN105473141A (zh) 2013-03-15 2016-04-06 实发生物医学公司 治疗和/或预防心血管疾病的抗pcsk9化合物和方法

Similar Documents

Publication Publication Date Title
JP2015518837A5 (https=)
RU2014151017A (ru) Способ получения гидроксилированных циклопентилпиримидинов
Barata‐Vallejo et al. Recent advances in trifluoromethylation reactions with electrophilic trifluoromethylating reagents
JP2012506425A5 (https=)
JP2015524409A5 (https=)
JP2012140458A5 (https=)
JP2015512868A5 (ja) ビニルエステル及び酢酸又はプロピオン酸反応生成物の共製造の第一段階としてのトランスビニル化
JP2014511367A5 (https=)
JP2013147496A5 (ja) 有機金属錯体
JP2015516945A5 (https=)
JP2013521295A5 (https=)
JP2009235096A5 (https=)
JP2016515039A5 (https=)
JP2016540036A5 (https=)
EP4357020A3 (en) Asymmetric phase transfer catalysis
BR112018004447A2 (pt) derivado de biarila e medicamento contendo o mesmo
RU2019119584A (ru) Способ получения триазолопиридинового соединения
JP2017509581A5 (https=)
JP2014520075A5 (https=)
HRP20180948T1 (hr) Postupak za proizvodnju aminokiselinskih spojeva
JP2016539168A5 (https=)
JP2013241421A5 (https=)
AU2012264476A8 (en) Process for the preparation of paliperidone
RU2016112136A (ru) Способ получения 1,1-дибром-1-фторэтана
JP2015536305A5 (https=)